日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical Impact of Obesity on Postoperative Outcomes of Patients With Thyroid Cancer Undergoing Thyroidectomy: A 5-Year Retrospective Analysis From the US National Inpatient Sample

肥胖对甲状腺癌患者行甲状腺切除术后结局的临床影响：一项基于美国全国住院样本的5年回顾性分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70335
Chen, Yue; Jin, Jiewen; Zhang, Pengyuan; Ye, Runyi; Zeng, Chuimian; Zhang, Yilin; Chen, Junxin; Li, Hai; Xiao, Haipeng; Li, Yanbing; Guan, Hongyu
肿瘤
肿瘤免疫
代谢
甲状腺癌
肥胖
免疫/内分泌
发表日期：2024
文献求助 收藏

Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancer

整合的免疫相关基因特征可预测 Luminal B 型乳腺癌患者的临床结局

期刊:Gland Surgery
影响因子:1.6
doi:10.21037/gs-24-377
Xie, Zhen; Cai, Du; Ye, Runyi; Shan, Zhen; Lin, Ying; Gao, Feng; Shao, Nan; Kuang, Xiaying
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer

PARP抑制剂在HER2阴性乳腺癌患者中的应用前景

期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.30721
Shao, Nan; Shi, Yawei; Yu, Liang; Ye, Runyi; Shan, Zhen; Zhang, Zhanqiang; Zhang, Yunjian; Lin, Ying
肿瘤
HER2
肿瘤免疫
乳腺癌
PARP
发表日期：2019
文献求助 收藏

Correction to: IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma

更正：IGFBP7 通过抑制 AKT 活性和细胞周期进程来抑制甲状腺癌的细胞增殖

期刊:Cell and Bioscience
影响因子:6.2
doi:10.1186/s13578-019-0319-6
Zhang, Le; Lian, Rong; Zhao, Jingjing; Feng, Xianming; Ye, Runyi; Pan, Lingxiao; Wu, Jueheng; Li, Mengfeng; Huang, Yongbo; Cai, Junchao
肿瘤
肿瘤免疫
甲状腺癌
细胞生物学
AKT
免疫/内分泌
发表日期：2019
文献求助 收藏

Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.

美国癌症联合委员会 (AJCC) 第 7 版和第 8 版乳腺癌患者分期系统的比较：监测、流行病学和最终结果 (SEER) 分析

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S185212
Shao Nan, Xie Chuanbo, Shi Yawei, Ye Runyi, Long Jianting, Shi Huijuan, Shan Zhen, Thompson Alastair M, Lin Ying
肿瘤
乳腺癌
肿瘤免疫
发表日期：2019
文献求助 收藏

AFF3 upregulation mediates tamoxifen resistance in breast cancers

AFF3上调介导乳腺癌细胞对三苯氧胺的耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-018-0928-7
Shi, Yawei; Zhao, Yang; Zhang, Yunjian; AiErken, NiJiati; Shao, Nan; Ye, Runyi; Lin, Ying; Wang, Shenming
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2018
文献求助 收藏

Prognostic value of tumor-infiltrating Foxp3+ regulatory T cells in patients with breast cancer: a meta-analysis

肿瘤浸润性Foxp3+调节性T细胞在乳腺癌患者中的预后价值：一项荟萃分析

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.21030
Zhou, Yu; Shao, Nan; Aierken, Nijiati; Xie, Chuanbo; Ye, Runyi; Qian, Xueke; Hu, Ziye; Zhang, Jin; Lin, Ying
肿瘤
T细胞
肿瘤免疫
乳腺癌
T细胞
细胞生物学
免疫/内分泌
发表日期：2017
文献求助 收藏